Other OTC Pharmaceuticals - Algeria

  • Algeria
  • The revenue in the Other OTC Pharmaceuticals market in Algeria is recorded at US$268.10m in 2024.
  • It is projected to experience an annual growth rate of 1.12% (CAGR 2024-2029).
  • Amongst countries worldwide, the in the United States generates the highest revenue, reaching US$7,171.00m in 2024.
  • In terms of per capita figures, the revenue generated per person in Algeria amounts to US$5.79 in 2024.
  • Algeria's market for Other OTC Pharmaceuticals is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Algeria is experiencing significant growth and development in recent years. Customer preferences in the market are largely driven by the increasing demand for self-medication and the availability of a wide range of over-the-counter (OTC) products. Consumers in Algeria are becoming more proactive in managing their own health and are seeking accessible and affordable healthcare solutions. This has led to a growing preference for OTC pharmaceuticals, as they offer convenience and cost-effectiveness compared to prescription medications. Additionally, the rising awareness about preventive healthcare and the importance of early intervention has further fueled the demand for OTC products in the country.Trends in the market indicate a shift towards natural and herbal remedies. Consumers in Algeria are increasingly seeking OTC pharmaceuticals that are derived from natural sources and have minimal side effects. This trend is driven by the growing interest in alternative medicine and the perception that natural remedies are safer and more sustainable. As a result, there has been a surge in the availability of natural and herbal OTC products in the market, catering to the evolving preferences of consumers.Another notable trend in the market is the increasing adoption of online retail channels. E-commerce platforms have gained popularity in Algeria, providing consumers with easy access to a wide range of OTC pharmaceuticals. This trend is driven by the convenience and competitive pricing offered by online retailers, as well as the growing penetration of smartphones and internet connectivity in the country. The shift towards online retail channels has also enabled consumers in remote areas to access OTC products that may not be readily available in their local pharmacies.Local special circumstances in Algeria, such as the high prevalence of chronic diseases, have contributed to the growth of the Other OTC Pharmaceuticals market. Chronic diseases, such as diabetes and hypertension, require long-term management and often require OTC medications for symptom relief. The increasing incidence of these diseases has created a steady demand for OTC pharmaceuticals in the country.Underlying macroeconomic factors, such as the steady economic growth and increasing disposable income, have also played a role in the development of the market. As the economy in Algeria continues to grow, consumers have more purchasing power to spend on healthcare products, including OTC pharmaceuticals. This has created a favorable environment for market players to expand their product offerings and invest in marketing and distribution channels.In conclusion, the Other OTC Pharmaceuticals market in Algeria is experiencing growth and development driven by customer preferences for self-medication, the trend towards natural and herbal remedies, the increasing adoption of online retail channels, local special circumstances, and underlying macroeconomic factors.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)